Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1381531/000119312514064774/d637393d10k.htm
January 2022
December 2021
December 2021
December 2021
November 2021
October 2021
September 2021
August 2021
August 2021
August 2021
Exhibit 99.1
![]() |
395 de Maisonneuve Blvd. West Montreal, QC H3A 1L6 | |
![]() |
TICKER SYMBOL | MEDIA AND INVESTOR RELATIONS | |||||||||
(NYSE: UFS) (TSX: UFS) | Pascal Bossé Vice-President Corporate Communications and Investor Relations Tel.: 514-848-5938 |
DOMTAR CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FISCAL YEAR 2013 FINANCIAL RESULTS
Acquired Laboratorios Indas, Spanish market leader in adult incontinence a key milestone in the development of Domtars Personal Care business
(All financial information is in U.S. dollars, and all earnings per share results are diluted, unless otherwise noted.)
| Fourth quarter 2013 net earnings of $2.00 per share, earnings before items1 of $2.09 per share |
| Announced and completed on January 2, 2014, the acquisition of Laboratorios Indas, Spains largest manufacturer and marketer of adult incontinence products |
| Completed a long-term financing with the successful issuance of 30-year senior notes |
Montreal, February 7, 2014 Domtar Corporation (NYSE: UFS) (TSX: UFS) today reported net earnings of $65 million ($2.00 per share) for the fourth quarter of 2013 compared to net earnings of $27 million ($0.82 per share) for the third quarter of 2013 and net earnings of $19 million ($0.54 per share) for the fourth quarter of 2012. Sales for the fourth quarter of 2013 were $1,359 million.
Excluding items listed below, the Company had earnings before items1 of $68 million ($2.09 per share) for the fourth quarter of 2013 compared to earnings before items1 of $41 million ($1.25 per share) for the third quarter of 2013 and earnings before items1 of $46 million ($1.31 per share) for the fourth quarter of 2012.
Fourth quarter 2013 items:
| Net gain on sale of property, plant and equipment and business for $5 million ($4 million after tax); and |
| Charge of $7 million ($7 million after tax) for impairment of property, plant and equipment. |
Third quarter 2013 items:
| Loss on sale of business of $19 million ($12 million after tax); and |
| Negative impact of purchase accounting of $2 million ($2 million after tax). |
1 | Non-GAAP financial measure. Refer to the Reconciliation of Non-GAAP Financial Measures in the appendix. |
1 / 12
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1381531/000119312514064774/d637393d10k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Domtar Corp.
Domtar Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Domtar Corp provided additional information to their SEC Filing as exhibits
Ticker: UFS
CIK: 1381531
Form Type: 10-K Annual Report
Accession Number: 0001193125-14-064774
Submitted to the SEC: Mon Feb 24 2014 3:09:31 PM EST
Accepted by the SEC: Mon Feb 24 2014
Period: Tuesday, December 31, 2013
Industry: Paper Mills